Hyperphosphatemia Stocks List
Symbol | Grade | Name | % Change | |
---|---|---|---|---|
OPK | D | OPKO Health Inc. | 12.15 | |
ARDX | D | Ardelyx, Inc. | 1.08 |
Related Industries: Biotechnology Drug Manufacturers - Specialty & Generic
Symbol | Grade | Name | Weight | |
---|---|---|---|---|
SURI | B | Simplify Exchange Traded Funds Simplify Propel Opportunities ETF | 2.8 | |
PTH | C | Invesco DWA Healthcare Momentum ETF | 2.67 | |
GERM | D | ETFMG Treatments Testing and Advancements ETF | 1.86 | |
DWAS | B | PowerShares DWA SmallCap Technical Leaders Portfolio | 1.44 | |
BBC | C | Virtus LifeSci Biotech Clinical Trials ETF | 1.0 |
Compare ETFs
- Hyperphosphatemia
Hyperphosphatemia is an electrolyte disorder in which there is an elevated level of phosphate in the blood. Most people have no symptoms while others develop calcium deposits in the soft tissue. Often there is also low calcium levels which can result in muscle spasms.Causes include kidney failure, pseudohypoparathyroidism, hypoparathyroidism, diabetic ketoacidosis, tumor lysis syndrome, and rhabdomyolysis. Diagnosis is generally based on a blood phosphate levels of greater than 1.46 mmol/L (4.5 mg/dL). When levels are greater than 4.54 mmol/L (14 mg/dL) it is deemed severe. Levels may appear falsely elevated with high blood lipid levels, high blood protein levels, or high blood bilirubin levels.Treatment may include eating a phosphate low diet and antacids, like calcium carbonate, that bind phosphate. Occasionally intravenous normal saline or dialysis may be used. How commonly it occurs is unclear.
Popular Now
Recent Comments
- TraderMike on Market Recap for Friday, March 8, 2024
- Don_Marat on Market Recap for Friday, March 8, 2024
- TraderMike on Trades of the Week: Feb 12 - Feb 16, 2024
- Cos3 on Trades of the Week: Feb 12 - Feb 16, 2024
- SwingTradeBot on Market Recap for Tuesday, February 27, 2024
From the Blog
Featured Articles